Dynamic perfluorinated gas MRI reveals abnormal ventilation despite normal FEV1 in cystic fibrosis-Reference-Cited by-同舟云学术

Dynamic perfluorinated gas MRI reveals abnormal ventilation despite normal FEV1 in cystic fibrosis

Published:2020-01-30 Issue:2 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Goralski Jennifer L.^ORCID,Chung Sang Hun,Glass Tyler M.,Ceppe Agathe S.,Akinnagbe-Zusterzeel Esther O.,Trimble Aaron T.,Boucher Richard C.,Soher Brian J.^ORCID,Charles H. Cecil^ORCID,Donaldson Scott H.^ORCID,Lee Yueh Z.^ORCID

Funder

Cystic Fibrosis Foundation

NIH Clinical Center

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/133400/files/pdf

Reference25 articles.

1. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis;Gustafsson;Thorax,2008

2. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT

3. Assessment of Morphological MRI for Pulmonary Changes in Cystic Fibrosis (CF) Patients

4. Magnetic resonance-compatible-spirometry: principle, technical evaluation and application

5. Magnetic Resonance Imaging of the Lung in Cystic Fibrosis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging in Pediatric Lung Disease;Clinics in Chest Medicine;2024-09

2. Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or twoF508delalleles;European Respiratory Journal;2024-06-20

3. Proximal and Distal Bronchioles Contribute to the Pathogenesis of Non-Cystic Fibrosis Bronchiectasis (NCFB);American Journal of Respiratory and Critical Care Medicine;2023-11-28

4. Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy;The Lancet Respiratory Medicine;2023-10

5. Structural changes in lung morphology detected by MRI after modulating therapy with elexacaftor/tezacaftor/ivacaftor in adolescent and adult patients with cystic fibrosis;Respiratory Medicine;2023-09